Insider Trading January 30, 2026

Amprius CTO Disposes $476K Worth of Shares as Company Executes $100M ATM and CEO Transition Nears

Stefan Constantin Ionel sells nearly 40,000 shares on Jan. 28, 2026; Amprius completes at-the-market offering and formalizes leadership change for 2026

By Priya Menon AMPX
Amprius CTO Disposes $476K Worth of Shares as Company Executes $100M ATM and CEO Transition Nears
AMPX

Amprius Technologies' Chief Technology Officer Stefan Constantin Ionel sold 39,690 shares of common stock on January 28, 2026, realizing roughly $476,351. The same day he exercised options to acquire 39,690 shares at strike prices between $0.05 and $0.62, for a total exercise cost of $2,035. After these moves, Ionel holds 748,696 shares directly, including 585,697 restricted stock units. Separately, Amprius closed a $100 million at-the-market equity program that produced about $97.5 million in net proceeds from 25.5 million shares. The company is also undergoing a leadership transition, with Tom Stepien to assume the CEO role effective January 1, 2026, while current CEO Dr. Kang Sun will step down at the end of 2025 to become an Executive Advisor and remain on the board. Broker activity around the company includes Oppenheimer retaining an Outperform rating and Needham initiating coverage with a Buy rating and a $20.00 price target. Changes to Dr. Sun's employment agreement effective January 2026 were also disclosed.

Key Points

  • CTO Stefan Constantin Ionel sold 39,690 shares on January 28, 2026, for approximately $476,351 at $12.0018 per share and exercised options to acquire the same number of shares for $2,035 in total.
  • After the transactions, Ionel directly owns 748,696 shares of Amprius common stock, including 585,697 restricted stock units.
  • Amprius completed a $100 million at-the-market equity offering, selling 25.5 million shares and netting roughly $97.5 million, while formalizing a CEO transition effective January 1, 2026.

Amprius Technologies, Inc. reported a series of insider and corporate financing moves at the end of 2025 and the start of 2026 that coincide with an upcoming change in executive leadership.

On January 28, 2026, Chief Technology Officer Stefan Constantin Ionel sold 39,690 shares of the company's common stock at a per-share price of $12.0018, generating proceeds of approximately $476,351. That same day, Ionel exercised options to acquire 39,690 shares of Amprius common stock. The exercised options carried strike prices that ranged from $0.05 to $0.62, and the total cost of exercising those options was $2,035.

Following the exercise and the sale, Ionel's direct holdings in Amprius amount to 748,696 shares of common stock. That total includes 585,697 restricted stock units that remain part of his direct ownership position.


Separately, Amprius completed an at-the-market (ATM) equity offering with an $100 million program. The company sold 25.5 million shares under that program and generated approximately $97.5 million in net proceeds from the sale.

Those financing activities come as Amprius prepares for a formal management transition. Tom Stepien is scheduled to take over as chief executive officer effective January 1, 2026. Current CEO Dr. Kang Sun will step down as CEO at the end of 2025 and will move into an Executive Advisor role beginning in January 2026, while remaining a member of the Board of Directors. The company also announced changes to Dr. Sun's employment agreement effective January 2026 that outline his compensation and benefits after the transition.

Market analysts have noted the leadership turnover in their coverage. Oppenheimer has maintained an Outperform rating on Amprius, describing the leadership change as a new phase for the company. Needham has launched coverage with a Buy rating and a $20.00 price target, specifically highlighting Amprius' footprint in the unmanned aerial systems battery market.

Taken together, the insider transaction, the ATM offering and the management handover mark a period of coordinated financial and governance activity at Amprius as it moves into 2026.

Risks

  • Insider share sale and option exercise may raise questions among investors about insider liquidity and timing - relevant to equity markets and investor sentiment.
  • The issuance of 25.5 million shares under the ATM program could affect share supply and market dynamics for Amprius common stock - relevant to capital markets and shareholder value.
  • Leadership transition to a new CEO and changes to the outgoing CEO's employment agreement introduce execution and governance uncertainty during the handover period - relevant to corporate governance and operational continuity.

More from Insider Trading

Symbotic Accounting Chief Disposes $457,722 in Shares as Company Prices 10M-Share Offering; Goldman Lowers Rating Feb 2, 2026 Wintrust Financial EVP Sells 5,000 Shares as Firm Announces Dividend Hike and Multiple Price-Target Upgrades Jan 30, 2026 Cantor Fitzgerald Affiliates Dispose of Satellogic Shares in $2.94M Transaction Block Jan 30, 2026 Navan Interim CFO Executes $37,044 Sell-to-Cover Transaction Jan 30, 2026 Bluescape entity disposes of $4.2M in Riley Exploration stock amid company asset sale and capital actions Jan 30, 2026